24-26 April 2018

San Francisco, USA


The 5th annual RNA-Seq meeting  will  provide a vital forum for scientists, bioinformaticians and pharmaceutical business leaders to come up to speed with the latest advances in RNA-Seq technologies and analytical tools, and address key challenges surrounding their practical application to drug development and the clinic.

What’s new to RNA-Seq 2017?

  • Discover new cases studies giving you unprecedented access to both the data and results of how RNA-Seq is being applied successfully from bench to bedside
  • Gain new insights into RNA-Seq for the study of toxicity, IO, host-viral interactions and more from companies such as BMS, Janssen, Pfizer, Merck, UCSC and Stanford
  • Explore new solutions to:
    • Roadblocks in applying single cell and other emerging RNA sequencing technologies in the clinic
    • Accurately interpreting the vast amounts of data in unpicking the complexity of the transcriptome
    • Integrating and mining of RNA-Seq data for drug discovery research
    • Novel and innovative RNA-Seq methods to understand the impact of tissue composition and cellular  interactions

Download the agenda for the complete agenda and speaker faculty.

"Excellent panel of speakers providing a comprehensive overview of the field in just 2 days"

Gereon Lauer,
Associate Director Clinical Biomarker,
Vertex Pharmaceuticals